Last reviewed · How we verify
Pilot Randomized-controlled Trial of Integrated Palliative and Nephrology Care Versus Usual Nephrology Care.
The objective of this application is to conduct a pilot study testing the impact of integrated nephrology and palliative care versus standard nephrology care on patient-reported outcomes. This study is a preliminary study designed to determine feasibility of a palliative care study inclusive of kidney disease patients and to look for trends in impact over a 12-week follow-up period. Measurements will be taken at time one (time of enrollment) and time two (12 weeks). Our central hypothesis is that integration of palliative care with standard nephrology care in the ambulatory care of patients with a glomerular filtration rate (eGFR) ≤15ml/min/1.73m2 will trend towards improved symptom control, quality of life, and increased documentation of advance care planning when compared to usual nephrology care. We expect 10-15 patients per arm.
Details
| Lead sponsor | NYU Langone Health |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | COMPLETED |
| Enrolment | 45 |
| Start date | Sun Jul 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Chronic Kidney Diseases
Interventions
- Integrated ambulatory palliative and nephrology care
- Standard nephrology care
Countries
United States